What is Alignment Healthcare, Inc.'s earnings per share (EPS)?

Alignment Healthcare, Inc. (ALHC) reported diluted earnings per share of $0.00 for fiscal year 2025. This represents a 100.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Alignment Healthcare, Inc. Financials

ALHC

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Alignment Healthcare, Inc. (ALHC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ALHC FY2025 2026-04-22

Revenue scale is finally outrunning overhead, shifting Alignment’s model from funded growth toward internally generated cash and breakeven economics.

From FY2023 to FY2025, revenue scale moved from $1.82B to $3.95B while SG&A rose far more slowly. That spread turned a -7.0% operating margin into 0.4%, showing fixed-cost absorption after several years of improvement: the administrative platform is finally being covered by growth instead of expanding in lockstep with it.

FY2025 free cash flow reached $113.1M while net income was almost flat at -$724K, so cash generation improved faster than accounting earnings. That matters because earlier losses also consumed cash; now expansion looks much less dependent on outside financing or balance-sheet support.

The balance sheet is better than the old loss profile implied: cash was $575.8M and long-term debt was $323.2M in FY2025. But with only $179.3M of equity against $886.5M of liabilities, the company has operating liquidity without yet having a large shock absorber.

Financial Health Signals

Financial Profile 40/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Alignment Healthcare, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Alignment Healthcare, Inc. has an operating margin of 0.4%, meaning the company retains $0 of operating profit per $100 of revenue. This below-average margin results in a low score of 17/100, suggesting thin profitability after operating expenses. This is up from -3.8% the prior year.

Growth

100

Alignment Healthcare, Inc.'s revenue surged 46.1% year-over-year to $3.9B, reflecting rapid business expansion. This strong growth earns a score of 100/100.

Leverage

Alignment Healthcare, Inc. carries a low D/E ratio of 1.80, meaning only $1.80 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 65/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Alignment Healthcare, Inc.'s current ratio of 1.71 indicates adequate short-term liquidity, earning a score of 30/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Alignment Healthcare, Inc.'s free cash flow margin of 2.9% results in a low score of 26/100. Capital expenditures of $26.8M absorb a large share of operating cash flow.

Returns

Alignment Healthcare, Inc. generates a -0.4% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is up from -128.2% the prior year.

Altman Z-Score Safe

5.80

Alignment Healthcare, Inc. scores 5.80, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($4.3B) relative to total liabilities ($886.5M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Neutral

5/9

Alignment Healthcare, Inc. passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

-193.27x

For every $1 of reported earnings, Alignment Healthcare, Inc. generates $-193.27 in operating cash flow ($139.9M OCF vs -$724K net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk

0.9x

Alignment Healthcare, Inc. earns $0.9 in operating income for every $1 of interest expense ($14.8M vs $15.8M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$3.9B

YoY+46.1%

5Y CAGR+32.7%

Alignment Healthcare, Inc. generated $3.9B in revenue in fiscal year 2025. This represents an increase of 46.1% from the prior year.

EBITDA

$45.2M

YoY+160.5%

5Y CAGR+35.6%

Alignment Healthcare, Inc.'s EBITDA was $45.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 160.5% from the prior year.

Net Income

-$724K

YoY+99.4%

Alignment Healthcare, Inc. reported -$724K in net income in fiscal year 2025. This represents an increase of 99.4% from the prior year.

EPS (Diluted)

$0.00

YoY+100.0%

Alignment Healthcare, Inc. earned $0.00 per diluted share (EPS) in fiscal year 2025. This represents an increase of 100.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$113.1M

YoY+1802.0%

Alignment Healthcare, Inc. generated $113.1M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 1802.0% from the prior year.

Cash & Debt

$575.8M

YoY+33.0%

5Y CAGR+22.7%

Alignment Healthcare, Inc. held $575.8M in cash against $323.2M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

204M

YoY+6.5%

5Y CAGR+4.5%

Alignment Healthcare, Inc. had 204M shares outstanding in fiscal year 2025. This represents an increase of 6.5% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

0.4%

YoY+4.1pp

5Y CAGR+0.9pp

Alignment Healthcare, Inc.'s operating margin was 0.4% in fiscal year 2025, reflecting core business profitability. This is up 4.1 percentage points from the prior year.

Net Margin

-0.0%

YoY+4.7pp

5Y CAGR+2.4pp

Alignment Healthcare, Inc.'s net profit margin was -0.0% in fiscal year 2025, showing the share of revenue converted to profit. This is up 4.7 percentage points from the prior year.

Return on Equity

-0.4%

YoY+127.8pp

5Y CAGR+74.5pp

Alignment Healthcare, Inc.'s ROE was -0.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 127.8 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

$26.8M

YoY-35.3%

Alignment Healthcare, Inc. invested $26.8M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 35.3% from the prior year.

ALHC Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$3.9B+46.1%	$2.7B+48.3%	$1.8B+27.2%	$1.4B+22.8%	$1.2B+21.7%	$959.2M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$443.4M+19.4%	$371.4M+20.8%	$307.4M+4.0%	$295.6M+1.6%	$291.0M+86.1%	$156.4M
Operating Income	$14.8M+114.5%	-$101.6M+20.5%	-$127.8M+0.6%	-$128.6M+27.8%	-$178.1M-3283.5%	-$5.3M
Interest Expense	$15.8M-32.9%	$23.5M+10.9%	$21.2M+16.1%	$18.3M+4.9%	$17.4M+3.0%	$16.9M
Income Tax	$20K-4.8%	$21K+195.5%	-$22K-106.5%	$339K	$0	$0
Net Income	-$724K+99.4%	-$128.0M+13.5%	-$148.0M+1.0%	-$149.5M+23.4%	-$195.3M-751.8%	-$22.9M
EPS (Diluted)	$0.00+100.0%	$-0.67+15.2%	$-0.79+4.8%	$-0.83+27.2%	$-1.14-660.0%	$-0.15

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$1.0B+1.9%	$993.7M-2.1%	$1.0B+9.5%	$926.9M+32.2%	$701.2M+1.3%	$692.4M+1.6%	$681.3M+8.4%	$628.6M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$125.8M+14.3%	$110.0M+6.0%	$103.8M0.0%	$103.8M+1.7%	$102.1M+12.4%	$90.9M+3.4%	$87.9M-2.9%	$90.5M
Operating Income	-$10.3M-233.9%	$7.7M-66.2%	$22.7M+521.8%	-$5.4M+76.1%	-$22.5M-15.5%	-$19.5M-6.2%	-$18.4M+55.3%	-$41.1M
Interest Expense	$3.9M0.0%	$4.0M0.0%	$4.0M0.0%	$4.0M-28.1%	$5.5M-20.8%	$6.9M+21.9%	$5.7M+4.9%	$5.4M
Income Tax	-$3.2M-161450.0%	$2K-99.9%	$3.2M+15252.4%	$21K+200.0%	$7K+187.5%	-$8K-136.4%	$22K	$0
Net Income	-$11.0M-395.1%	$3.7M-76.2%	$15.7M+271.9%	-$9.1M+70.7%	-$31.1M-17.7%	-$26.4M-10.0%	-$24.0M+48.4%	-$46.5M
EPS (Diluted)	N/A	$0.02-71.4%	$0.07+240.0%	$-0.05	N/A	$-0.14-7.7%	$-0.13+48.0%	$-0.25

ALHC Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$1.1B+36.3%	$782.1M+32.1%	$591.9M-6.6%	$633.9M+0.5%	$630.9M+86.4%	$338.5M
Current Assets	$951.6M+43.8%	$661.6M+36.8%	$483.5M-11.2%	$544.5M-1.5%	$552.9M+108.9%	$264.7M
Cash & Equivalents	$575.8M+33.0%	$432.9M+113.3%	$202.9M-50.5%	$409.5M-12.2%	$466.6M+125.1%	$207.3M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$253.2M+64.5%	$153.9M+28.5%	$119.7M+28.9%	$92.9M+58.8%	$58.5M+45.8%	$40.1M
Goodwill	$32.1M-7.9%	$34.8M0.0%	$34.8M0.0%	$34.8M+18.8%	$29.3M0.0%	$29.3M
Total Liabilities	$886.5M+30.2%	$681.1M+57.0%	$433.8M+9.9%	$394.6M+21.5%	$324.8M+5.5%	$307.9M
Current Liabilities	$556.9M+58.3%	$351.8M+33.8%	$263.0M+14.4%	$230.0M+37.5%	$167.2M+9.0%	$153.5M
Long-Term Debt	$323.2M+0.5%	$321.4M+98.6%	$161.8M+0.6%	$160.9M+6.8%	$150.6M+4.5%	$144.2M
Total Equity	$179.3M+79.5%	$99.9M-36.4%	$156.9M-34.1%	$238.1M-22.2%	$306.0M+899.8%	$30.6M
Retained Earnings	-$1.0B-0.1%	-$1.0B-14.5%	-$880.3M-20.2%	-$732.2M-25.7%	-$582.7M-53.5%	-$379.6M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$1.1B-3.3%	$1.1B+10.2%	$1.0B+11.7%	$895.6M+14.5%	$782.1M+13.0%	$692.3M-3.3%	$716.3M+13.1%	$633.2M
Current Assets	$951.6M-3.4%	$985.3M+12.0%	$880.1M+13.6%	$774.5M+17.1%	$661.6M+15.3%	$573.6M-4.3%	$599.1M+15.1%	$520.6M
Cash & Equivalents	$575.8M-6.8%	$618.1M+31.4%	$470.3M+5.4%	$446.2M+3.1%	$432.9M+27.2%	$340.3M+0.4%	$339.0M+41.9%	$238.9M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$253.2M+15.2%	$219.8M-22.3%	$282.9M+32.2%	$214.1M+39.1%	$153.9M+10.8%	$138.9M-24.2%	$183.2M+11.0%	$165.1M
Goodwill	$32.1M0.0%	$32.1M0.0%	$32.1M-6.2%	$34.2M-1.8%	$34.8M0.0%	$34.8M0.0%	$34.8M0.0%	$34.8M
Total Liabilities	$886.5M-5.8%	$940.7M+9.5%	$859.2M+9.2%	$786.6M+15.5%	$681.1M+18.1%	$576.7M-2.5%	$591.5M+18.0%	$501.2M
Current Liabilities	$556.9M-8.9%	$611.1M+15.4%	$529.5M+15.8%	$457.1M+29.9%	$351.8M-1.7%	$358.1M-3.6%	$371.5M+12.3%	$330.7M
Long-Term Debt	$323.2M+0.1%	$322.7M+0.1%	$322.3M+0.1%	$321.9M+0.1%	$321.4M+52.8%	$210.4M-0.6%	$211.7M+30.7%	$162.0M
Total Equity	$179.3M+10.8%	$161.9M+14.8%	$141.0M+30.4%	$108.1M+8.3%	$99.9M-12.8%	$114.5M-7.4%	$123.7M-5.5%	$130.9M
Retained Earnings	-$1.0B-1.1%	-$998.0M+0.4%	-$1.0B+1.5%	-$1.0B-0.9%	-$1.0B-3.2%	-$977.2M-2.8%	-$950.8M-2.6%	-$926.8M

ALHC Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$139.9M+302.4%	$34.8M+158.7%	-$59.2M-30.3%	-$45.4M+42.3%	-$78.8M-1141.9%	$7.6M
Capital Expenditures	$26.8M-35.3%	$41.4M+15.1%	$36.0M+51.4%	$23.8M	N/A	N/A
Free Cash Flow	$113.1M+1802.0%	-$6.6M+93.0%	-$95.2M-37.5%	-$69.2M	N/A	N/A
Investing Cash Flow	-$15.0M-138.2%	$39.2M+126.6%	-$147.3M-421.9%	-$28.2M-35.6%	-$20.8M-27.2%	-$16.4M
Financing Cash Flow	$18.0M-88.4%	$156.0M+148498.1%	$105K-99.4%	$16.6M-95.4%	$360.1M+176.8%	$130.1M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	$0	$0-100.0%	$1.5M-2.1%	$1.5M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	-$50.4M-134.8%	$144.6M+396.2%	$29.1M+75.3%	$16.6M+290.7%	-$8.7M-133.3%	$26.2M+11.3%	$23.5M+477.2%	-$6.2M
Capital Expenditures	$5.0M-8.5%	$5.5M-31.3%	$8.0M-3.0%	$8.3M-11.1%	$9.3M0.0%	$9.3M-20.9%	$11.7M+5.5%	$11.1M
Free Cash Flow	-$55.4M-139.8%	$139.1M+558.2%	$21.1M+152.6%	$8.4M+146.5%	-$18.0M-206.4%	$16.9M+43.4%	$11.8M+168.0%	-$17.4M
Investing Cash Flow	-$7.2M-409.4%	$2.3M+134.7%	-$6.7M-92.5%	-$3.5M+41.5%	-$5.9M+75.9%	-$24.6M-191.1%	$27.0M-36.9%	$42.7M
Financing Cash Flow	$15.3M+1513.5%	$948K-41.3%	$1.6M+792.8%	$181K-99.8%	$106.9M	$0-100.0%	$49.5M+14872.5%	-$335K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

ALHC Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	0.4%+4.1pp	-3.8%+3.2pp	-7.0%+2.0pp	-9.0%+6.3pp	-15.3%-14.7pp	-0.5%
Net Margin	-0.0%+4.7pp	-4.7%+3.4pp	-8.1%+2.3pp	-10.4%+6.3pp	-16.7%-14.3pp	-2.4%
Return on Equity	-0.4%+127.8pp	-128.2%-33.9pp	-94.3%-31.5pp	-62.8%+1.0pp	-63.8%+11.1pp	-74.9%
Return on Assets	-0.1%+16.3pp	-16.4%+8.6pp	-25.0%-1.4pp	-23.6%+7.4pp	-30.9%-24.2pp	-6.8%
Current Ratio	1.71-0.2	1.88+0.0	1.84-0.5	2.37-0.9	3.31+1.6	1.72
Debt-to-Equity	1.80-1.4	3.22+2.2	1.03+0.4	0.68+0.2	0.49-4.2	4.71
FCF Margin	2.9%+3.1pp	-0.3%+5.0pp	-5.2%-0.4pp	-4.8%	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	-1.0%-1.8pp	0.8%-1.5pp	2.2%+2.8pp	-0.6%+2.6pp	-3.2%-0.4pp	-2.8%-0.1pp	-2.7%+3.8pp	-6.5%
Net Margin	-1.1%-1.5pp	0.4%-1.2pp	1.5%+2.5pp	-1.0%+3.5pp	-4.4%-0.6pp	-3.8%-0.3pp	-3.5%+3.9pp	-7.4%
Return on Equity	-6.1%-8.4pp	2.3%-8.8pp	11.1%+19.5pp	-8.4%+22.7pp	-31.1%-8.1pp	-23.1%-3.7pp	-19.4%+16.1pp	-35.5%
Return on Assets	-1.0%-1.4pp	0.3%-1.2pp	1.6%+2.6pp	-1.0%+3.0pp	-4.0%-0.2pp	-3.8%-0.5pp	-3.4%+4.0pp	-7.3%
Current Ratio	1.71+0.1	1.61-0.0	1.66-0.0	1.69-0.2	1.88+0.3	1.60-0.0	1.61+0.0	1.57
Debt-to-Equity	1.80-0.2	1.99-0.3	2.29-0.7	2.98-0.2	3.22+1.4	1.84+0.1	1.71+0.5	1.24
FCF Margin	-5.5%-19.5pp	14.0%+11.9pp	2.1%+1.2pp	0.9%+3.5pp	-2.6%-5.0pp	2.4%+0.7pp	1.7%+4.5pp	-2.8%

Similar Companies

Oscar Health Inc OSCR

$4.9B

Progyny, Inc. PGNY

$1.5B

Clover Health Investments Corp CLOV

$1.2B

Molina Hlthcare MOH

$7.8B

Cvs Health Corp CVS

$98.1B

Frequently Asked Questions

What is Alignment Healthcare, Inc.'s annual revenue?

Alignment Healthcare, Inc. (ALHC) reported $3.9B in total revenue for fiscal year 2025. This represents a 46.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Alignment Healthcare, Inc.'s revenue growing?

Alignment Healthcare, Inc. (ALHC) revenue grew by 46.1% year-over-year, from $2.7B to $3.9B in fiscal year 2025.

Is Alignment Healthcare, Inc. profitable?

No, Alignment Healthcare, Inc. (ALHC) reported a net income of -$724K in fiscal year 2025, with a net profit margin of -0.0%.

What is Alignment Healthcare, Inc.'s EBITDA?

Alignment Healthcare, Inc. (ALHC) had EBITDA of $45.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Alignment Healthcare, Inc. have?

As of fiscal year 2025, Alignment Healthcare, Inc. (ALHC) had $575.8M in cash and equivalents against $323.2M in long-term debt.

What is Alignment Healthcare, Inc.'s operating margin?

Alignment Healthcare, Inc. (ALHC) had an operating margin of 0.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Alignment Healthcare, Inc.'s net profit margin?

Alignment Healthcare, Inc. (ALHC) had a net profit margin of -0.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Alignment Healthcare, Inc.'s return on equity (ROE)?

Alignment Healthcare, Inc. (ALHC) has a return on equity of -0.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Alignment Healthcare, Inc.'s free cash flow?

Alignment Healthcare, Inc. (ALHC) generated $113.1M in free cash flow during fiscal year 2025. This represents a 1802.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Alignment Healthcare, Inc.'s operating cash flow?

Alignment Healthcare, Inc. (ALHC) generated $139.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Alignment Healthcare, Inc.'s total assets?

Alignment Healthcare, Inc. (ALHC) had $1.1B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Alignment Healthcare, Inc.'s capital expenditures?

Alignment Healthcare, Inc. (ALHC) invested $26.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does Alignment Healthcare, Inc. have outstanding?

Alignment Healthcare, Inc. (ALHC) had 204M shares outstanding as of fiscal year 2025.

What is Alignment Healthcare, Inc.'s current ratio?

Alignment Healthcare, Inc. (ALHC) had a current ratio of 1.71 as of fiscal year 2025, which is generally considered healthy.

What is Alignment Healthcare, Inc.'s debt-to-equity ratio?

Alignment Healthcare, Inc. (ALHC) had a debt-to-equity ratio of 1.80 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Alignment Healthcare, Inc.'s return on assets (ROA)?

Alignment Healthcare, Inc. (ALHC) had a return on assets of -0.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Alignment Healthcare, Inc.'s Altman Z-Score?

Alignment Healthcare, Inc. (ALHC) has an Altman Z-Score of 5.80, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Alignment Healthcare, Inc.'s Piotroski F-Score?

Alignment Healthcare, Inc. (ALHC) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Alignment Healthcare, Inc.'s earnings high quality?

Alignment Healthcare, Inc. (ALHC) has an earnings quality ratio of -193.27x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Alignment Healthcare, Inc. cover its interest payments?

Alignment Healthcare, Inc. (ALHC) has an interest coverage ratio of 0.9x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Alignment Healthcare, Inc.?

Alignment Healthcare, Inc. (ALHC) scores 40 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.